Merck (MRK) Q3 2026 Earnings Call Transcript
On its third-quarter 2026 earnings call, Merck discussed generic headwinds ahead in 2027 alongside new product launches and growth of its WINREVAIR medicine.
fool.com ·
Supported Assets
Open Mo
Merck
24/7
-
-over selected period
-since US close
- Last close
- $144.67
- Premium / discount
- -
Updated Reference Yahoo Finance ·
Price differences before fees and execution costs. Compare prices
News
Merck One of Top Large-Cap Biopharma Picks-Analyst
Benzinga reported that Merck beat Q3 estimates on oncology strength and raised guidance, and that Guggenheim is watching pipeline progress ahead of Keytruda patent loss.
benzinga.com ·
Token
- Token
- MRKc
- Shares per token
- 1.00000000 MRK